Literature DB >> 11422151

Influenza virus A stimulates expression of eotaxin by nasal epithelial cells.

M Kawaguchi1, F Kokubu, H Kuga, T Tomita, S Matsukura, H Suzaki, S K Huang, M Adachi.   

Abstract

BACKGROUND: Respiratory virus is one of the most common causes of airway inflammation, but its pathogenic mechanisms are not well understood. Eotaxin is a potent eosinophil chemoattractant and is a selective agonist for C-C chemokine receptor 3 (CCR3). Although it has recently been demonstrated that epithelial cells express eotaxin, both in vivo and in vitro, there are few data concerning the expression in viral infection. OBJECTS: We hypothesized that eotaxin may play an important role in attracting inflammatory cells into the airway after viral infection and analysed whether viral infection induces eotaxin in nasal epithelial cells in vitro.
METHODS: Nasal epithelial cells obtained from polypectomy for nasal polyp were infected with influenza virus A (subtype H3N2). The cells and supernatants were collected 8, 24 and 48 h after infection. Eotaxin mRNA was analysed by RT-PCR. Eotaxin concentration in the supernatants was analysed by enzyme-linked immunosorbent assay. We also examined a blocking assay to analyse the intervention of pro-inflammatory cytokines, TNF-alpha and IL-1beta in eotaxin production induced by influenza virus.
RESULTS: The results showed that eotaxin was expressed constitutively in uninfected cells, but was up-regulated for both mRNA and protein levels in infected cells. Blocking experiments using anti-TNF-alpha and anti-IL-1beta antibodies showed no effects of these agents on the level of eotaxin. In addition, UV-inactivated virus did not enhance the expression of eotaxin.
CONCLUSIONS: These results suggest that influenza virus A infection in nasal epithelial cells stimulates the expression of eotaxin, and may play an important role in the pathogenesis of airway inflammation by inducing eotaxin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11422151     DOI: 10.1046/j.1365-2222.2001.01103.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  9 in total

1.  Detection of respiratory viruses and the associated chemokine responses in serious acute respiratory illness.

Authors:  Kaharu C Sumino; Michael J Walter; Cassandra L Mikols; Samantha A Thompson; Monique Gaudreault-Keener; Max Q Arens; Eugene Agapov; David Hormozdi; Anne M Gaynor; Michael J Holtzman; Gregory A Storch
Journal:  Thorax       Date:  2010-07       Impact factor: 9.139

2.  Role of CCL11 in eosinophilic lung disease during respiratory syncytial virus infection.

Authors:  Stephen P Matthews; John S Tregoning; Anthony J Coyle; Tracy Hussell; Peter J M Openshaw
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

3.  Cytokine and Chemokine Profiling in Patients with Hand, Foot and Mouth Disease in Singapore and Malaysia.

Authors:  Fiona Mei Shan Teo; Min Nyo; Anng Anng Wong; Natalie Woon Hui Tan; Mia Tuang Koh; Yoke Fun Chan; Chia Yin Chong; Justin Jang Hann Chu
Journal:  Sci Rep       Date:  2018-03-06       Impact factor: 4.379

Review 4.  Respiratory viral infections drive chemokine expression and exacerbate the asthmatic response.

Authors:  Matthew Schaller; Cory M Hogaboam; Nicholas Lukacs; Steven L Kunkel
Journal:  J Allergy Clin Immunol       Date:  2006-08       Impact factor: 10.793

Review 5.  Alternative Experimental Models for Studying Influenza Proteins, Host-Virus Interactions and Anti-Influenza Drugs.

Authors:  Sonja C J H Chua; Hui Qing Tan; David Engelberg; Lina H K Lim
Journal:  Pharmaceuticals (Basel)       Date:  2019-09-30

6.  Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 Infection.

Authors:  Alexander M Horspool; Theodore Kieffer; Brynnan P Russ; Megan A DeJong; M Allison Wolf; Jacqueline M Karakiozis; Brice J Hickey; Paolo Fagone; Danyel H Tacker; Justin R Bevere; Ivan Martinez; Mariette Barbier; Peter L Perrotta; F Heath Damron
Journal:  mSphere       Date:  2021-01-20       Impact factor: 4.389

7.  Time evolution of cytokine profiles associated with mortality in COVID-19 hospitalized patients.

Authors:  Laura Sánchez-de Prada; Óscar Gorgojo-Galindo; Inmaculada Fierro; Ana María Martínez-García; Guillermo Sarmentero-López de Quintana; Rocío Gutiérrez-Bustillo; María Teresa Pelaez-Jareño; Elisa Álvarez-Fuente; Esther Gómez-Sánchez; Eduardo Tamayo; Álvaro Tamayo-Velasco; Marta Martín-Fernández
Journal:  Front Immunol       Date:  2022-09-27       Impact factor: 8.786

Review 8.  Respiratory viruses and eosinophils: exploring the connections.

Authors:  Helene F Rosenberg; Kimberly D Dyer; Joseph B Domachowske
Journal:  Antiviral Res       Date:  2009-04-16       Impact factor: 5.970

9.  Broad-spectrum drugs against viral agents.

Authors:  Mary E Christopher; Jonathan P Wong
Journal:  Int J Mol Sci       Date:  2008-09-01       Impact factor: 6.208

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.